Seller: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
Seller: INDOO, Avenel, NJ, U.S.A.
Condition: New. Brand New.
Condition: New. pp. 380 1st Edition.
Condition: New. pp. 380.
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. pp. 380.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition.
Language: English
Published by John Wiley and Sons Inc, US, 2011
ISBN 10: 0470261234 ISBN 13: 9780470261231
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
Hardback. Condition: New. The first book to focus on comprehensive systems biology as applied to drug discovery and development Drawing on real-life examples, Systems Biology in Drug Discovery and Development presents practical applications of systems biology to the multiple phases of drug discovery and development. This book explains how the integration of knowledge from multiple sources, and the models that best represent that integration, inform the drug research processes that are most relevant to the pharmaceutical and biotechnology industries. The first book to focus on comprehensive systems biology and its applications in drug discovery and development, it offers comprehensive and multidisciplinary coverage of all phases of discovery and design, including target identification and validation, lead identification and optimization, and clinical trial design and execution, as well as the complementary systems approaches that make these processes more efficient. It also provides models for applying systems biology to pharmacokinetics, pharmacodynamics, and candidate biomarker identification. Introducing and explaining key methods and technical approaches to the use of comprehensive systems biology on drug development, the book addresses the challenges currently facing the pharmaceutical industry. As a result, it is essential reading for pharmaceutical and biotech scientists, pharmacologists, computational modelers, bioinformaticians, and graduate students in systems biology, pharmaceutical science, and other related fields.
Language: English
Published by Wiley-Blackwell 2011-11-18, 2011
ISBN 10: 0470261234 ISBN 13: 9780470261231
Seller: Chiron Media, Wallingford, United Kingdom
Hardcover. Condition: New.
Condition: New. Brand new! Please provide a physical shipping address.
Language: English
Published by John Wiley & Sons Inc, 2011
ISBN 10: 0470261234 ISBN 13: 9780470261231
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 1st edition. 380 pages. 9.75x6.75x1.00 inches. In Stock.
Language: English
Published by John Wiley and Sons Inc, US, 2011
ISBN 10: 0470261234 ISBN 13: 9780470261231
Seller: Rarewaves.com UK, London, United Kingdom
Hardback. Condition: New. The first book to focus on comprehensive systems biology as applied to drug discovery and development Drawing on real-life examples, Systems Biology in Drug Discovery and Development presents practical applications of systems biology to the multiple phases of drug discovery and development. This book explains how the integration of knowledge from multiple sources, and the models that best represent that integration, inform the drug research processes that are most relevant to the pharmaceutical and biotechnology industries. The first book to focus on comprehensive systems biology and its applications in drug discovery and development, it offers comprehensive and multidisciplinary coverage of all phases of discovery and design, including target identification and validation, lead identification and optimization, and clinical trial design and execution, as well as the complementary systems approaches that make these processes more efficient. It also provides models for applying systems biology to pharmacokinetics, pharmacodynamics, and candidate biomarker identification. Introducing and explaining key methods and technical approaches to the use of comprehensive systems biology on drug development, the book addresses the challenges currently facing the pharmaceutical industry. As a result, it is essential reading for pharmaceutical and biotech scientists, pharmacologists, computational modelers, bioinformaticians, and graduate students in systems biology, pharmaceutical science, and other related fields.